Singapore: Indian pharmaceutical company Strides Shasun limited has launched a share sale to raise funds up to Rs1,500 crore, IFR reported on Friday, citing a source close to the transaction.
Strides is selling shares at Rs 1,278 apiece in the transaction, which comprises a base deal for Rs 1,000 crore with an upsize option of Rs 500 crore, IFR, a Thomson Reuters publication, said.
Axis and Jefferies are the bookrunners for the deal, it said.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
